Fig 2.
Cumulative incidence of relapse in a cohort of 327 children with ALL according to (A) adherence to oral mercaptopurine (solid and dashed lines represent nonadherers [< 95%] and adherers [≥ 95%], respectively) and (B) ethnicity (solid and dashed lines represent Hispanics and non-Hispanic whites, respectively).